Archive for Abortion Pill Connections

Who is footing the bill for ‘free’ abortion pills on California college campuses?

Posted in Abortion Pill Connections, Abortion Pill Horrors, Abortion Pills Campus, Buffett Foundation, California abortion stats, DANCO, self-managed abortion, Songs, TARA Health Foundation, Women’s Foundation of California with tags , , , , , , , , , , , , , , , , , , , , , , , on October 20, 2019 by saynsumthn

abortion pill

A measure to force public universities to offer dangerous abortion pills on college campus, recently signed into law by California Governor Gavin Newsom, will initially be set up using funds from pro-abortion groups. However, pro-life student group Students for Life of America (SFLA) notes that student fees will also be used to fund on-campus abortions, since those fees underwrite the costs of campus healthcare centers. SFLA also pointed out how the conscience rights of students and healthcare workers will be violated if forced to participate with abortions. “This law includes funds that can go to Planned Parenthood for ‘consulting’ and new funds for ‘security’, allowing the nation’s number one abortion vendor to sit back and cash checks, enjoying the chaos of abortions taking place at schools without any of the risk,” said SFLA president Kristin Hawkins.

The bill requires student health care services centers at the state’s 34 University of California (UC) and California State University (CSU) campuses to offer medication abortion on and after January 1, 2023. According to a Department of Financial Bill Analysis, SB 24 “establishes the College Student Health Center Sexual and Reproductive Health Preparation Fund under the administration of the Commission on the Status of Women and Girls.” It requires the Commission, whose current chair Alisha Wilkins previously worked for Planned Parenthood of the Pacific Southwest in Riverside, “to provide grants of $200,000 to each student health center, and a grant of $200,000 to both the UC and CSU system to become prepared to offer abortion by medication techniques and develop associated back-up medical supports.”

The abortion pill was brought into the U.S. by the Population Council, a eugenics organization which sought out investors to set up a highly secretive company — DANCO Laboratories — to manufacture the drug.

Investors included:

  • The Packard Foundation, which originally invested in 1996 to help keep DANCO afloat when it “ran short on funds”
  • The Buffett Foundation, identified by the Washington Post in 2000, writing, “The Buffett Foundation… made at least $2 million in interest-free loans to the Population Council… according to tax documents filed in 1995. That money was in turn used to conduct clinical trials of RU-486 [the abortion pill].”
  • George Soros (Open Society Foundations)
  • A number of other abortion pill investors chose to remain unnamed, according to internal documents reviewed by the Wall Street Journal
Packard Timeline shows it invested in abortion pill distributor

Packard Timeline shows it invested in abortion pill distributor

 

To update campus student health center procedures, provide training, and purchase equipment at UC, the Department’s analysis estimated:

  • One-time system wide readiness General Fund costs between $4.6 million to $7.8 million…
  • Ongoing General Fund costs of $2.2 million to $3.3 million commencing in 2023 to provide abortion by medication services in each campus student health center and provide access to 24-hour telehealth services.

At CSU, the initial costs were “unknown” but raised concerns it could likely range in the millions to low tens of millions of dollars.

Image: CSU on costs of law mandating abortion pills on California campuses (Image: CBS Sacramento)

CSU on costs of law mandating abortion pills on California campuses (Image: CBS Sacramento)

“While this bill and its sponsors indicate that private financing would cover all the costs associated with this bill, Finance notes this bill could create future General Fund cost pressures to the extent sufficient private funding cannot be raised to support readiness grants, the costs to comply with this bill’s requirements exceed the proposed grant funding, or to the extent the UC and CSU incur ongoing costs after January 1, 2023,” the analysis said.

zImage: Lila Rose on law mandating abortion pills on California campus (Image: Twitter)

Lila Rose on law mandating abortion pills on California campus (Image: Twitter)

According to a statement by the ACLU, a “[C]onsortium of funders, including the Women’s Foundation of California and Tara Health Foundation,” has raised the initial funds.

Tara Health Foundation (THF):

Image: TARA Health Foundation promotes abortion

TARA Health Foundation promotes abortion

The Women’s Foundation of California:

According to the Guttmacher Institute there were 132,680 abortions committed in California in 2017. A previous analysis by Live Action News revealed that taxpayers in the state paid over half a billion dollars (nearly $700 million) for abortions from 1989 to 2014. In 2017, the pro-abortion Advancing New Standards in Reproductive Health (ANSIRH) — a research group at the University of California, San Francisco (UCSF)’s Bixby Center for Global Reproductive Health, which trains abortion providers — estimated, “Approximately 23% of CSU students and 12% of UC students are enrolled in Medi-Cal.”

Image: Medi-Cal FFS abortion expenditures in California 1989 to 2014 (Image: Live Action News)

Medi-Cal FFS abortion expenditures in California 1989 to 2014 (Image: Live Action News)

“Students across UC and CSU campuses obtain 1,038 abortions each month,” ANSIRH wrote adding, “[W]e estimate there would be between 322-519 medication abortions occurring across UC and CSU campuses every month.”

SFLA claims there was no need for the law because abortion facilities are less than 6 miles from every California public university and college campus. The group also claims there are no safeguards are in place to protect women who may be dosed with the drugs without their consent. Live Action News previously documented how many of those behind the push for these dangerous pills to be readily available on campus are also pushing for FDA safety requirements to be lifted. To date, at least 24 women have died from the abortion pill and literally thousands have been hospitalized with serious complications.

    • This article is reprinted with permission. The original appeared here at Live Action News.

FDA: 24 women die from abortion pill, thousands of serious complications

Posted in AAPLOG, Abortion death, Abortion pill, Abortion Pill Connections, Abortion Pill Horrors, DANCO, Daniel Grossman, Generic Abortion Pill, Inc., Packard Foundation with tags , , , , , , , , , , , , , , , , , , , , , , , , on April 23, 2019 by saynsumthn

As more women die from abortion pill, the FDA approves a generic version

abortion pill, emergency contraception

 

The FDA has approved a generic version of the abortion pill Mifeprex, at a time when more deaths are being reported and the abortion industry is pushing for the dangerous abortion inducing chemicals to be dispensed online or by mail. According to a notice from the FDA, the generic version is approved for use as an abortifacient. This news comes just a day before the FDA updated its adverse effects reports through 2018, stating, “As of December 31, 2018, there were reports of 24 deaths of women associated with Mifeprex since the product was approved in September 2000, including two cases of ectopic pregnancy resulting in death; and several cases of severe systemic infection (also called sepsis), including some that were fatal…” The FDA’s 2017 report put the number of deaths at 22.

This means that in 2018 alone, two more women died from taking the abortion pill. And yet, now a generic version is going to be made available.

Abortion Pill Deaths December 2018

Dec 2018 abortion pill deaths FDA

To date, the report documents nearly 4,200 reported adverse effects, including hospitalization and other serious complications.

On April 11, 2019, the FDA approved GenBioPro, Inc.’s abbreviated new drug application for a generic Mifeprex, which, when used with Misoprostol is approved as an abortion pill regimen. The FDA states (emphasis added), “This approval reflects FDA’s determination that GenBioPro’s product, Mifepristone Tablets, 200 mg, is therapeutically equivalent to Mifeprex and can be safely substituted for Mifeprex. Like Mifeprex, the approved generic product is indicated for the medical termination of intrauterine pregnancy through 70 days gestation….”

READ: The secrecy surrounding the abortion pill’s maker and influential financial investors must end

Generic abortion pill by GenBioPro approved by FDA

The FDA also states clearly that although they modified the Mifeprex application to include “mifepristone products,” this change in no way removes the FDA’s REMS (Risk Evaluation and Mitigation Strategy), “a safety strategy to manage a known or potential serious risk associated with a medicine and to enable patients to have continued access to such medicines by managing their safe use.”

Of note, on April 11, 2019, FDA approved a supplemental application for Mifeprex, approving modifications to the existing approved REMS for Mifeprex to establish a single, shared system REMS for mifepristone products (including Mifeprex as well as the approved generic version of Mifeprex) for the medical termination of intrauterine pregnancy through 70 days gestation. In establishing the single, shared system REMS, no changes were made to the substantive elements of the REMS. This single, shared system REMS is known as the Mifepristone REMS Program.

Find approval information for this 2019 supplement here.

The approved generic version of Mifeprex generally has the same labeling as Mifeprex…Under the law, the approved generic version of Mifeprex is required to use a single, shared system REMS with the brand product, Mifeprex. This single, shared system REMS, known as the Mifepristone REMS Program, sets forth the distribution requirements that must be followed for both Mifeprex and the approved generic version of Mifeprex.

Requiring that the generic be subject to FDA’s REMS is good news for now, because, as Live Action News has previously reported, the abortion lobby is attempting to expand access to the abortion pills via mail order or pharmacy by pushing “self-managed abortion,” described by Guttmacher as ending a pregnancy “without direct supervision by a health care provider.” To accomplish this, REMS, must be eliminated.

READ: What you should know about the dangerous ‘self-managed’ abortion pill push

Dr. Donna Harrison, Executive Director American Association of Pro-Life Obstetricians and Gynecologists(AAPLOG), agreed, telling Live Action News (emphasis added):

Allowing a generic equivalent of Mifeprex basically means that the patent restrictions have run out. So, new drugs have a patent which is time limited… and in the case of Mifeprex, the patent was held by the Population Council. So, now that the patent has run out, generics are allowed. But this does not change the restrictions. REMS are still in place until FDA changes the restrictions. So, just to clarify, this does not mean that Mifeprex is OTC [over-the-counter]. It just changes how much quality control goes in to the pill manufacturing process and how much Danco can charge for the drug.

The move towards a generic drug is being hailed a victory by abortion advocates, specifically Dr. Daniel Grossman, who has deep tiesto the “self-managed” abortion pill push.

Image: FDA Approves generic abortion drug (Image Twitter Dr. Daniel Grossman)

FDA Approves generic abortion drug (Image Twitter Dr. Daniel Grossman)

Image: FDA Approves generic abortion drug NWHC (Image: Twitter)

FDA Approves generic abortion drug NWHC (Image: Twitter)

Under the Mifepristone REMS Program, the FDA states, “Mifeprex and the approved generic version of Mifeprex” may:

  • [O]nly be supplied directly to healthcare providers who are certified to prescribe the drug product and who meet certain qualifications.
  • [T]he products are only available to be dispensed in certain healthcare settings, specifically, clinics, medical offices and hospitals, by or under the supervision of a certified prescriber.
  • They are not available in retail pharmacies and are not legally available over the Internet.

The original drug (Mifeprex) was approved in 2000 after being brought to the U.S. by the eugenics-founded Population Council, and was seeded by the Packard Foundation among other pro-abortion philanthropy groups. They then set up a highly secretive company named Danco to manufacturer the drug.

The generic version is produced by GenBioPro, Inc., which also appears to have the financial support of abortion collaborators. In fact, Packard gave GenBioPro, Inc. $185,000 in 2016 and 100,000 in 2017. According to the Nevada Secretary of State, a 2007 filing for the company was permanently revoked. A new filing in 2011 is active and shows a registered agent of CSC Services of Nevada, Inc. and the only officer listed is E. Masingill.

The FDA warns consumers they should not buy Mifeprex or GenBioPro, Inc.’s approved generic version of Mifeprex, Mifepristone Tablets, 200 mg., over the Internet because they will bypass important safeguards designed to protect patient health.

    • This article is reprinted with permission. The original appeared here at Live Action News.